Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Viatris

Viatris

Viatris is a small Molecules, Generics founded in 1961.

Viatris was formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer. By integrating the strengths of these two companies, including our global workforce of ~40,000, we aim to deliver increased access to affordable, quality medicines for patients worldwide.

Our global portfolio includes best-in-class, iconic brand name products as well as global key brands; generics, including branded and complex generics; biosimilars; and over-the-counter offerings across a wide range of therapeutic areas. We are committed to helping create healthier communities worldwide through education, outreach and better access to treatment.

Timeline

Patents

Further Resources

Title
Author
Link
Type
Date

Mylan Pharmaceuticals Inc., a Viatris Company, Conducting Voluntary Recall of One Batch of Semglee® (insulin glargine injection), 100 units/mL (U-100), 3 mL Prefilled Pens, Due to the Potential for a Missing Label in the Batch

Web

18.01.2022

Viatris Announces 9% Dividend Increase, Fourth Consecutive Quarterly Dividend

Web

06.01.2022

Viatris is First to Receive FDA Approval of Generic Restasis® (Cyclosporine Ophthalmic Emulsion 0.05%) to Treat Dry Eye Disease

Web

03.02.2022

Viatris to Host Virtual Investor Event and Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2022

Web

04.02.2022

News

Title
Author
Date
Publisher
Description
Viatris Inc.
June 24, 2021
www.prnewswire.com:443
/PRNewswire/ -- Viatris (NASDAQ: VTRS) today announced that the U.S. District Court for the District of Kansas ruled, in substantial part, in Mylan's favor on...
Michael Sainato
June 20, 2021
the Guardian
The Viatris plant in West Virginia has been making pharmaceuticals since 1965 - but it's closing down and laying workers off
Aneesh Phadnis & Vinay Umarji
May 20, 2021
@bsindia
These developments come amid fast spread of the disease in various states and shortage of drugs to treat them.
Viatris Inc.
April 20, 2021
www.prnewswire.com:443
/PRNewswire/ -- El miércoles 21 de abril, entre las 8:00 a. m. y las 9:30 a. m. hora de verano del este, el Consejo Empresarial para el Entendimiento...
Theravance Biopharma, Inc.
February 23, 2021
www.prnewswire.com:443
/PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial results for the fourth quarter and...

References

Golden logo
By using this site, you agree to our Terms & Conditions.